These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2423786)

  • 1. Experimental evidence for the antiarrhythmic action of indoramin.
    Harron DW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S131-6. PubMed ID: 2423786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations into the bradycardic action of indoramin.
    Lillie C; Harron DW; Kobinger W
    Arzneimittelforschung; 1985; 35(1A):301-5. PubMed ID: 4039170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical cardiac electrophysiology of indoramin, a post-synaptic alpha blocker.
    Butrous GS; Camm AJ
    Eur Heart J; 1986 Jul; 7(7):576-83. PubMed ID: 3758091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a central sympathoinhibitory action of prazosin and indoramin.
    Ramage AG
    Eur J Pharmacol; 1986 Feb; 121(1):83-9. PubMed ID: 3956575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
    Harron DW; Kerr MJ; Shanks RG
    J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prazosin, indoramin and phentolamine on sympathetic nerve activity.
    Ramage AG
    Eur J Pharmacol; 1984 Nov; 106(3):507-13. PubMed ID: 6097460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs.
    Osadchii OE
    J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AQ-A 39 (5,6-dimethoxy-2-[3[[alpha-(3,4-dimethoxy)-phenylethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heart.
    Kobinger W; Lillie C
    Eur J Pharmacol; 1981 Jun; 72(2-3):153-64. PubMed ID: 7250205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indoramin, a drug with prevalent antihypertensive activity: experimental study].
    Marmo E; Rossi F; Caputi AP; Lampa E; Petrarca R; Ottavo R
    Clin Ter; 1979 Feb; 88(3):233-62. PubMed ID: 445975
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the renal effects of indoramin and prazosin.
    Strandhoy JW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S151-5. PubMed ID: 2423789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical cardiac electrophysiological assessment of indoramin.
    Butrous GS; Camm AJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioregulatory properties of indoramin in the rat.
    Algate DR; Rashid S; Waterfall JF
    J Pharm Pharmacol; 1981 Apr; 33(4):236-9. PubMed ID: 6115907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral contribution to the antihypertensive action of indoramin.
    Baum T; Shropshire AT
    Eur J Pharmacol; 1975 May; 32(1):30-8. PubMed ID: 168091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic and metabolic effects of indoramin during acute regional ischemia and reperfusion in isolated rat heart.
    Muller CA; Worthington MG; Thandroyen FT
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):408-13. PubMed ID: 1691364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology of indoramin.
    Shanks RG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S8-15. PubMed ID: 2423804
    [No Abstract]   [Full Text] [Related]  

  • 20. [Animal experimental studies on the pharmacology of a new anti-arrhythmic of the imino-cycloheptane series, stirocainide].
    Borchard U; Dénes B; Greeff K
    Arzneimittelforschung; 1984; 34(4):416-22. PubMed ID: 6540099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.